AAAAAA

   
Results: << | 101-125 | 126-150 | 151-175 | 176-200 | >>

Table of contents of journal: *Molecular medicine today (Regular ed.)

Results: 176-200/784

Authors: Higgins, LS
Citation: Ls. Higgins, Animal models of Alzheimer's disease, MOL MED TOD, 5(6), 1999, pp. 274-276

Authors: Brooksbank, C
Citation: C. Brooksbank, Disease models: relevance is everything, MOL MED TOD, 5(6), 1999, pp. 274-274

Authors: Kola, I Pritchard, M
Citation: I. Kola et M. Pritchard, Animal models of Down syndrome, MOL MED TOD, 5(6), 1999, pp. 276-277

Citation: Online access to Molecular Medicine Today, MOL MED TOD, 5(5), 1999, pp. 187-187

Authors: Senior, K
Citation: K. Senior, Alzheimer's disease: finding the missing link, MOL MED TOD, 5(5), 1999, pp. 188-189

Authors: Alfred, J
Citation: J. Alfred, Molecular changes herald a new era for cervical cancer screening, MOL MED TOD, 5(5), 1999, pp. 189-190

Authors: Sansom, C
Citation: C. Sansom, Rooting out new drugs, MOL MED TOD, 5(5), 1999, pp. 191-191

Authors: Senior, K
Citation: K. Senior, Are physician scientists close to extinction?, MOL MED TOD, 5(5), 1999, pp. 192-192

Authors: Caulfield, T Hirtle, M
Citation: T. Caulfield et M. Hirtle, Regulating the genetic revolution, MOL MED TOD, 5(5), 1999, pp. 198-200

Authors: Domen, J Weissman, IL
Citation: J. Domen et Il. Weissman, Self-renewal, differentiation or death: regulation and manipulation of hematopoietic stem cell fate, MOL MED TOD, 5(5), 1999, pp. 201-208

Authors: Schiller, JT
Citation: Jt. Schiller, Papillomavirus-like particle vaccines for cervical cancer, MOL MED TOD, 5(5), 1999, pp. 209-215

Authors: Baldwin, SA Mackay, JR Cass, CE Young, JD
Citation: Sa. Baldwin et al., Nucleoside transporters: molecular biology and implications for therapeutic development, MOL MED TOD, 5(5), 1999, pp. 216-224

Authors: Licinio, J Prolo, P McCann, SM Wong, ML
Citation: J. Licinio et al., Brain iNOS: current understanding and clinical implications, MOL MED TOD, 5(5), 1999, pp. 225-232

Authors: Senior, K
Citation: K. Senior, Ups and downs on the road to an HIV vaccine, MOL MED TOD, 5(4), 1999, pp. 141-142

Authors: Brooksbank, C
Citation: C. Brooksbank, Rapid update, MOL MED TOD, 5(4), 1999, pp. 142-142

Authors: Bonn, D
Citation: D. Bonn, Q fever vaccine on trial for type I diabetes, MOL MED TOD, 5(4), 1999, pp. 143-143

Authors: Fricker, J
Citation: J. Fricker, Human neural stem cells on trial for Parkinson's disease, MOL MED TOD, 5(4), 1999, pp. 144-144

Authors: Hnatowich, DJ
Citation: Dj. Hnatowich, Changing focus: applying antisense to nuclear medicine imaging, MOL MED TOD, 5(4), 1999, pp. 151-151

Authors: Senut, MC Gage, FH
Citation: Mc. Senut et Fh. Gage, Prenatal gene therapy: can the technical hurdles be overcome?, MOL MED TOD, 5(4), 1999, pp. 152-156

Authors: Hall, J Angele, S
Citation: J. Hall et S. Angele, Radiation, DNA damage and cancer, MOL MED TOD, 5(4), 1999, pp. 157-164

Authors: Levine, F Leibowitz, G
Citation: F. Levine et G. Leibowitz, Towards gene therapy of diabetes mellitus, MOL MED TOD, 5(4), 1999, pp. 165-171

Authors: Guilford, P
Citation: P. Guilford, E-cadherin downregulation in cancer: fuel on the fire?, MOL MED TOD, 5(4), 1999, pp. 172-177

Authors: Hicklin, DJ Marincola, FM Ferrone, S
Citation: Dj. Hicklin et al., HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story, MOL MED TOD, 5(4), 1999, pp. 178-186

Authors: Sansom, C
Citation: C. Sansom, Tandem mass spectrometry: the tool of choice for diagnosing inborn errors of metabolism, MOL MED TOD, 5(3), 1999, pp. 95-95

Authors: Fricker, J
Citation: J. Fricker, Visualizing gallstone formation, MOL MED TOD, 5(3), 1999, pp. 96-96
Risultati: << | 101-125 | 126-150 | 151-175 | 176-200 | >>